Generics 14

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Ropivacaine hydrochloride manufacturers

14 products found

Filters

14 products found

ropivacaine hydrochloride

Bags for injection/infusion 2 mg/ml - 100 ml, 200 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Belgium , France , Germany , Italy , Portugal , United Kingdom , Vietnam
Registered in
Belgium , France , Germany , Italy , Netherlands , Portugal , United Kingdom
Manufacturer #15084

Manufacturer usually replies in 18 days

ropivacaine hydrochloride

Solution for injection/infusion 2 mg/ml, 5 mg/ml, 7.5 mg/ml, 10 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Kosovo
Manufacturer #298

Manufacturer usually replies in 3 days

ropivacaine hydrochloride

Ampoules, injection 2 mg, 5 mg, 7.5 mg, 10 mg / ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #17477
A pharmaceutical manufacturer based in the EU that has partnerships with global pharmaceutical companies worldwide for 90+ years. The company's main therapeutic areas include anesthesia, cardiology, and infectivology. The manufacturing facilities are GMP approved and its activities for FDF and API are FDA approved.

Manufacturer usually replies in 7 days

ropivacaine hydrochloride

Vials, injection 2 mg / ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #17477
A pharmaceutical manufacturer based in the EU that has partnerships with global pharmaceutical companies worldwide for 90+ years. The company's main therapeutic areas include anesthesia, cardiology, and infectivology. The manufacturing facilities are GMP approved and its activities for FDF and API are FDA approved.

Manufacturer usually replies in 7 days

ropivacaine hydrochloride

Injection, pre-filled syringe 2mg/mL

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Available for
Distribution only
Comments
Can only sell this product directly to a hospital pharmacy as we would be making it under U.S. FDA 503B drug shortage regulations
Manufacturer #17737

Manufacturer usually replies in 5 days

ropivacaine hydrochloride

Vials, injection 2 mg/ml, 5 mg/ml, 10 mg/ml - 20 ml, 30 ml

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Comments
ANDA / R &D Status: Approved; US RLD / Holder: "Naropin / Fresenius Kabi"; Indication: Local Anesthetic;
Manufacturer #8216

Manufacturer usually replies in 6 days

ropivacaine hydrochloride

Bags for injection/infusion 2 mg/ml, 5 mg/ml - 100 ml, 200 ml

Dossier type
US CTD
Dossier status
Under development
Country of origin
India
GMP approvals
FDA
Comments
ANDA / R &D Status: ANDA to be filed in Q2-2023, approval expected Q2-2024; US RLD / Holder: "Naropin / Fresenius Kabi"; Indication: Local anesthetic;
Manufacturer #8216

Manufacturer usually replies in 6 days

ropivacaine hydrochloride

Powder for solution for injection 75 mg , 100 mg - 10 ml

Dossier type
CTD
Dossier status
Under development
Country of origin
China
GMP approvals
China
Manufacturer #12677

Manufacturer usually replies in 4 days

ropivacaine hydrochloride

Ampoules, injection 2 mg / ml, 7.5 mg / ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #18075
The mission of all pharmaceutical companies and employees is to fight disease and protect those who suffer or lose their lives. Therefore, the development, production, and supply of excellent pharmaceuticals are a fundamental responsibility of pharmaceutical companies. Based on the research, production, and sales capabilities from API to Drug products using purely their technology, they are leaping to become the global No. 1 bio & chemical-pharmaceutical company in various areas including next-generation biopharmaceuticals, from gene therapy to antibody therapy, cell therapy, and natural medicine.

Manufacturer usually replies in 9 days

ropivacaine hydrochloride

Injection 0.20%, 0.75%

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17417

Manufacturer usually replies in 6 days

ropivacaine hydrochloride

Injection 40 mg, 150 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19912

Manufacturer usually replies in 18 days

ropivacaine hydrochloride

Injection 7.5 mg, 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #21312
They are in the market since the 1960s. The mission is to produce quality medicines at a fair price, facilitating access and contributing to the solution of health problems. The vision is to stand out as one of the best National Laboratories providers of products and services for special treatments in the next 5 years.

Manufacturer usually replies in nan days

ropivacaine hydrochloride

Injection 2 mg, 5 mg, 7.5 mg, 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #28571

Manufacturer usually replies in nan days

ropivacaine hydrochloride

Powder for solution for injection 89.4 mg , 119.2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #31064